dc.contributor.author | Oner, P | |
dc.contributor.author | Oztas, B | |
dc.contributor.author | Kocak, H | |
dc.date.accessioned | 2021-03-05T11:23:19Z | |
dc.date.available | 2021-03-05T11:23:19Z | |
dc.identifier.citation | Oner P., Kocak H., Oztas B., "Effects of streptozotocin-induced diabetes and pentylenetetrazol-induced seizure on brain cortex Ca(2+)ATPase activity in rats", INTERNATIONAL JOURNAL OF NEUROSCIENCE, cilt.103, ss.33-40, 2000 | |
dc.identifier.issn | 0020-7454 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_a7f11199-8e19-427c-b097-0fad216c71cd | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/112245 | |
dc.identifier.uri | https://doi.org/10.3109/00207450009003250 | |
dc.description.abstract | The aim of the present study was to obtain information about the effects of pentylenetetrazol-induced status epileptious (SE) and streptozotocin-induced diabetes on brain cortex Ca2+ ATPase activity. Treatment with pentylenetetrazol (PTZ) and streptozotocin (STZ) to rats resulted in significant decrease in brain cortex Ca2+ ATPase activity as compared with controls. However, PTZ-treated diabetic rats had a slight but non-significant decrease in enzyme activity. Treatment with PTZ caused a more pronounced effect in inhibiting enzyme activity than that of treatment with STZ. Our results concluded that reduced brain cortex Ca2+ ATPase activity following PTZ and STZ treatments to rats, may be an initial biochemical lesion which triggers a sequence of events which may culminate in cell death. | |
dc.language.iso | eng | |
dc.subject | Sinirbilim ve Davranış | |
dc.subject | Temel Bilimler | |
dc.subject | NEUROSCIENCES | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.title | Effects of streptozotocin-induced diabetes and pentylenetetrazol-induced seizure on brain cortex Ca(2+)ATPase activity in rats | |
dc.type | Makale | |
dc.relation.journal | INTERNATIONAL JOURNAL OF NEUROSCIENCE | |
dc.contributor.department | , , | |
dc.identifier.volume | 103 | |
dc.identifier.startpage | 33 | |
dc.identifier.endpage | 40 | |
dc.contributor.firstauthorID | 124445 | |